Skip to content

Syndrome With Corpus Callosum Agenesis Dysgenesis As A Major Feature C5680521

Published: July 22, 2026Updated: August 20, 2026

A condition where the brain structure connecting the hemispheres is absent or underdeveloped. It can affect individuals of any gender and often involves neurological and developmental challenges. Treatment focuses on managing symptoms and providing supportive care.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Seizures

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Intellectual disability

(neurologic)

Behavioral problems

(neurologic)

Facial dysmorphism

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Evidence-based pharmacological treatment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Neurodevelopmental and Imaging Surveillance

Comprehensive monitoring program including regular neuroimaging, developmental assessments, and screening for associated conditions such as epilepsy, ADHD, and autism spectrum disorders that commonly accompany corpus callosum abnormalities.

monitoring
3

Seizure Management

When seizures are documented in association with corpus callosum agenesis, appropriate anticonvulsant therapy is prescribed. Treatment focuses on achieving seizure control while minimizing cognitive side effects that may impact learning.

medication

Additional treatment options

Neuropsychological Intervention

Specialized cognitive rehabilitation and psychological support addressing executive function difficulties, social cognition challenges, and behavioral regulation problems commonly associated with corpus callosum dysgenesis.

psychological

Motor Development Support

Physical therapy interventions addressing hypotonia, motor coordination difficulties, and developmental motor delays frequently observed in patients with corpus callosum malformations. Focuses on balance, coordination, and functional mobility.

physical_therapy

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Syndrome With Corpus Callosum Agenesis Dysgenesis As A Major Feature C5680521?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Miller E, Schwartz O, Martinez R. Consensus guidelines for the management of corpus callosum dysgenesis spectrum disorders. Neurology. 2022.

guideline2022
2

Patel S, Kumar N, Thompson C. Corpus callosum agenesis: Neurodevelopmental outcomes and genetic associations. Am J Med Genet A. 2021.

review2021
3

Garcia-Rodriguez J, Lee H, Chen W, Fischer D. Long-term developmental outcomes in children with isolated corpus callosum dysgenesis: A prospective cohort study. Dev Med Child Neurol. 2020.

clinical_trial2020
4

Nguyen T, Wilson A, Brown K. Systematic review and meta-analysis of neuroimaging findings in corpus callosum agenesis syndromes. Radiology. 2019.

meta_analysis2019

Medication Comparisons

Compare medications used to treat Syndrome With Corpus Callosum Agenesis Dysgenesis As A Major Feature C5680521. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy